Fibrocell Science competitorsClear all

Fibrocell Science's top competitors include Nordic Nanovector, Y-mAbs Therapeutics, Adagene and Topas Therapeutics.
Fibrocell Science
Fibrocell Science
Fibrocell Science is an autologous cell and gene therapy company.
Nordic Nanovector
Nordic Nanovector
Nordic Nanovector, a biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics in hematology and oncology.
Y-mAbs Therapeutics
Y-mAbs Therapeutics
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
Adagene
Adagene
Adagene is an antibody discovery and development biotechnology company.
Topas Therapeutics
Topas Therapeutics
Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis.
Founding Date
Founding Date
1995
Founding Date
2009
Founding Date
2014
Founding Date
2012
Founding Date
2013
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Exton, US HQ
Locations
Oslo, NO HQ
Zug, CH
Shrewsbury, GB
Locations
New York, US HQ
Hørsholm, DK
Nutley, US
Nutley, US
Locations
Suzhou, CN HQ
Locations
Hamburg, DE HQ
Employees
Employees
195% decrease
Employees
40
Employees
3239% increase
Employees
484% increase
Employees
N/A
Valuation ($)
Valuation ($)
29.3 m
Valuation ($)
132.2 m
Valuation ($)
1.5 b
Valuation ($)
N/A
Valuation ($)
N/A
Alexa Website Rank
Alexa Website Rank
307433
Alexa Website Rank
446150
Alexa Website Rank
N/A
Alexa Website Rank
273440
Alexa Website Rank
N/A

Financial

Net income
Net income
($10.3m) (FY, 2018)
Net income
N/A
Net income
($81m) (FY, 2019)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 69m (5 months ago)
Latest funding round
$ 5m (over 2 years ago)
Total funding raised
Total funding raised
$ 115m
Total funding raised
N/A
Total funding raised
$ 80m
Total funding raised
$ 155m
Total funding raised
$ 20.8m
For sources of this data, please see the company profile

View company profiles

Nordic Nanovector
HQ
Oslo, NO
Employees
40

Nordic Nanovector, a biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics in hematology and oncology.

View company
Y-mAbs Therapeutics
HQ
New York, US
Employees
32↑ 39% increase

Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.

View company
Adagene
HQ
Suzhou, CN
Employees
48↑ 4% increase

Adagene is an antibody discovery and development biotechnology company.

View company
Topas Therapeutics
HQ
Hamburg, DE

Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis.

View company